Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • PrecisionLife and Metrodora Institute Partner to Accelerate the Diagnosis and Treatment of Long COVID, ME/CFS, and other Chronic Conditions

    Feb 15, 2024, 08:45 AM by
    PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.
    Full story
  • New Vaccinology Rulebook Needed To Outsmart ‘Part-Time Pathogens’

    Feb 15, 2024, 08:37 AM by User Not Found
    Bio-IT World | Researchers at University of California San Diego School of Medicine have found that the rules of vaccinology need to be reversed for Staphylococcus aureus (SA), the common and sometimes dangerous bacteria that humans encounter shortly after birth and are continuously exposed to for the remainder of their life.
    Full story
  • Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test

    Feb 14, 2024, 09:04 AM by
    Alzheimer’s Research & Therapy: Linus Health Digital Clock and Recall Test Detects Early Cognitive Impairment in Over 80% of Patients Who Were Misclassified in Commonly Used Paper-Based Test
    Full story
  • Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation

    Feb 14, 2024, 09:04 AM by
    Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation
    Full story
  • Study Establishes ENPP1 As A Biomarker For Immunotherapy Benefit

    Feb 14, 2024, 00:00 AM by User Not Found
    Bio-IT World | Researchers in California have shown that breast cancer patients with RNA expression levels of ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) in the bottom 50th percentile can confidently be treated with Keytruda (pembrolizumab) as well as surgery. Their cancer would have a zero percent chance of metastasizing in seven years.
    Full story
  • HM Lord-Lieutenant of Cambridgeshire Opens Domainex’s New Biology Centre of Excellence and Presents the King’s Award for Enterprise

    Feb 13, 2024, 11:15 AM by
    Domainex, a leading drug discovery and integrated medicines research partner based in Cambridge UK, opens a new Biology Centre of Excellence to further support collaborations with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions globally.
    Full story
  • Monoclonal Antibodies Stand as Beacons of Hope in Cancer Treatment, Offering Remarkable Advancements in the Fight Against this Relentless Disease!

    Feb 13, 2024, 11:15 AM by
    In 2022, the latest data from the International Agency for Research on Cancer's Global Cancer Observatory indicates that ten specific types of cancer collectively represented approximately two-thirds of both new cases and fatalities worldwide. Covering 185 countries and 36 different types of cancer, the rising demand for biologics, including monoclonal antibodies and immunotherapies, has surged due to the increasing incidence of cancer. These innovative treatments are revolutionizing cancer care by enhancing survival rates and minimizing adverse effects.
    Full story
  • Novel NGS-Based Assay Has Seemingly Limitless Virus Detection Potential

    Feb 13, 2024, 01:00 AM by User Not Found
    Bio-IT World | Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health have created a next-generation sequencing (NGS) technology that employs oligonucleotides (oligos)—short single strands of synthetic DNA—as bait for relevant targets of detection.
    Full story
  • BioTeam Awarded 3 Year NIH Contract to Advance Genomics Research

    Feb 9, 2024, 09:16 AM by
    BioTeam, Inc. has been awarded a contract by the National Human Genome Research Institute (NHGRI) to enhance its data ecosystem, accelerating genomic discoveries and improving human health outcomes.
    Full story
  • AES Clean Technology enhances cleanroom construction capabilities through new senior appointment

    Feb 9, 2024, 09:16 AM by
    Full story
  • Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies

    Feb 9, 2024, 09:16 AM by
    Abzena launches LabZient™, an analytical platform accelerating antibody development timelines by combining predictive in-silico evaluation with laboratory methods. LabZient™ streamlines assessment, reduces costs, and enables early measurement of critical quality attributes. Fit-for-purpose across various antibody types, including mAbs and ADCs, LabZient™ enhances efficiency in biopharma development.
    Full story
  • GenAI’s Real Potential in Biopharma: As a Cross-Function R&D Assistant

    Feb 9, 2024, 01:00 AM by User Not Found
    Bio-IT World | In biopharma R&D there is growing momentum around the use of Generative AI, the deep-learning algorithms capable of distilling complex knowledge into easily digestible summaries. But so far companies have been relatively modest in their ambitions for the technology.
    Full story
  • Cotiviti Named 2024 Best in KLAS® for Payer Quality Measurement and Reporting

    Feb 8, 2024, 08:17 AM by
    Cotiviti announced they won 2024 Best in KLAS: Software & Services for its Quality Intelligence solution, which enables health plans to track, monitor, and improve quality compliance. With top feedback from its clients and other healthcare executives, Cotiviti earned the highest ratings in five of KLAS’s Customer Experience Pillars.
    Full story
  • ZeOmega Named Best in KLAS® for Payer Care Management Solutions in 2024

    Feb 8, 2024, 08:17 AM by
    Today ZeOmega, a population health management company, was named Best in KLAS for Payer Care Management Solutions for the third consecutive year. The newly released 2024 Best in KLAS: Software & Services Report recognized ZeOmega as a leader in its market category. This designation follows a record growth year in 2023 that included: 94% client retention, 16% client base expansion New tech partners (such as Microsoft) to enhance automation capabilities Product innovations and AI implementations that address care quality, utilization management, member engagement, and risk adjustment
    Full story
  • Watson-Marlow to demonstrate latest fluid path technologies at MD&M West

    Feb 8, 2024, 08:17 AM by
    Devens, MA, US / 30th January 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range specially designed for medical devices and diagnostic instruments at MD&M West in Anaheim, CA, from February 6-8.
    Full story
  • Alfa Chemistry Releases Carbomer Series Products for Cosmetics and Personal Care Products Manufacturing

    Feb 8, 2024, 08:17 AM by
    Full story
  • Watson-Marlow Fluid Technology Solutions to Showcase Fluid Path Product Range at ISPE Rocky Mountain and ISPE CaSA

    Feb 8, 2024, 08:17 AM by
    Visit booth 70 at Rocky Mountain ISPE Vendor Show and booth 943 at ISPE CaSA Annual Tech Show to meet Watson-Marlow engineers and discuss the company’s expert fluid path solutions
    Full story
  • ResultsCX Named ‘Disruptor’ in Avasant’s Contact Center Business Process Transformation 2023-2024 RadarView™ Assessment

    Feb 7, 2024, 08:10 AM by
    Full story
  • Clearwater and 1stResponder Partner to Expand Cybersecurity Incident Response within Clearwater's Managed Security Service Provider (MSSP) Portfolio

    Feb 7, 2024, 08:10 AM by
    Full story
  • From Ordinary to Extraordinary: CD Formulation's Remarkable Food Ingredient Launch

    Feb 7, 2024, 08:09 AM by
    Full story
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46 (current)
  • 47
  • 48
  • 49
  • 50
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy